Apple’s ambitions in the digital health technology sector continue to expand with its latest acquisition of Gliimpse, a startup that aims to make it easier for patients to manage their personal health records and data. Although Apple frequently purchases smaller companies, they rarely formally announce their acquisitions. However, the tech giant did confirm the Gliimpse purchase to Fast Company earlier this week, revealing that is was the first acquisition by Apple’s new digital health team and that it occurred earlier this year.
Gliimpse is a secure personal platform that enables users to collect, personalize, and share a picture of their health records and medical information, which is in line with Apple’s larger mission of combining user’s various health data in one central location so it is easier for them to manage and share with health providers.
The tech startup’s product collates medical information into an easy-to-read profile for the patient and takes “incomprehensible electronic medical records and turns them into understandable, standardized, coded elements, and terminology that both humans and machines can easily understand and use.”
It remains unknown exactly how Apple plans to use the technology or whether the product will remain in its current form or if Apple plans to augment it.
The Gliimpse acquisition will bolster Apple’s ongoing efforts of further exploring digital health technology. In recent years, Apple has delved into the sector with a range of services (HealthKit, CareKit, and ResearchKit) that allow patients, clinicians, and researchers to access important health and wellness data via a range of mobile devices, which is in line with Gliimpse’s mission of uniting disparate streams of health information.
However, what is unique about Gliimpse is that it’s intended for chronically ill patients with diseases like cancer and diabetes.
The Silicon Valley-based company was started by serial entrepreneurs Anil Sethi and Karthik Hariharan in 2013, after Sethi watched his sister battle breast cancer.
Gliimpse’s basic version is free to use for regular consumers, but there is an enterprise version that employers could subscribe to for a fee.